-
Product Insights
ARMHC – Children’s Healthcare of Atlanta House – Georgia
The ARMHC – Children's Healthcare of Atlanta House – Georgia project involves the construction of a 9,104m2 Children's Healthcare of Atlanta House on 1.6ha of land in Atlanta, Georgia, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our ARMHC – Children's Healthcare of Atlanta House – Georgia report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Product Insights
RCHSD – Rady Children’s Hospital Expansion – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our RCHSD – Rady Children’s Hospital Expansion – California report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of the project’s...
-
Product Insights
NewLikelihood of Approval Analysis for Burkitt Lymphoma
Overview How likely is it that the drugs in Burkitt Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Burkitt Lymphoma Overview Burkitt lymphoma is an aggressive and fast-growing type of...
-
Product Insights
NewLikelihood of Approval Analysis for Growth Disorders
Overview How likely is it that the drugs in Growth Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Growth Disorders Overview Growth disorders are problems that prevent children from developing...
-
Product Insights
NewLikelihood of Approval Analysis for Malaria
Overview How likely is it that the drugs in Malaria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malaria Overview Malaria is a life-threatening blood disease caused by a parasite (Plasmodium)...
-
Product Insights
NewLikelihood of Approval Analysis for Allergic Rhino-Conjunctivitis
Overview How likely is it that the drugs in Allergic Rhino-Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergic Rhino-Conjunctivitis Overview Allergic Rhino-Conjunctivitis is an allergen-induced inflammatory response mediated by...
-
Company Insights
Innovation and Patenting activity of The Children~s Place Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of The Children~s Place Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval Analysis for Paramyxoviridae Infections
Overview How likely is it that the drugs in Paramyxoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paramyxoviridae Infections Overview The Paramyxoviridae family belongs to the order Mononegavirales, the...
-
Product Insights
NewLikelihood of Approval Analysis for Hemophagocytic Lymphohistiocytosis
Overview How likely is it that the drugs in Hemophagocytic Lymphohistiocytosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hemophagocytic Lymphohistiocytosis Overview Hemophagocytic lymphohistiocytosis (HLH), also known as hemophagocytic or haemophagocytic...
-
Product Insights
NewLikelihood of Approval Analysis for Respiratory Syncytial Virus (RSV) Infections
Overview How likely is it that the drugs in Respiratory Syncytial Virus (RSV) Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Syncytial Virus (RSV) Infections Overview Respiratory syncytial virus...